Gilead CEO On 2024 drug pipeline: Expect results from around two dozen clinical trials

Поделиться
HTML-код
  • Опубликовано: 10 дек 2024

Комментарии • 15

  • @FlavioMarceloSousa35
    @FlavioMarceloSousa35 5 месяцев назад +2

    Gilead must ensure fair access to lenacapavir ASAP, this new HIV treatment is a game changer.

  • @leedreams7820
    @leedreams7820 9 месяцев назад +4

    it was last chance to escape that stock

  • @tsav6952
    @tsav6952 8 месяцев назад +2

    Gilead is a vital healthcare company to the world. I think their science will someday cure certain cancers.

    • @metalcraze
      @metalcraze 5 месяцев назад

      Do you really think Pharma industry want to cure cancer? It's a lifetime money making business industry and you really want the public to believe that nonsense?

    • @michaelrogers9720
      @michaelrogers9720 3 месяца назад

      @@metalcraze gilead is better than most of them

    • @metalcraze
      @metalcraze 2 месяца назад

      @@michaelrogers9720 Can you tell us who those are?

  • @SundayAnyebe
    @SundayAnyebe 4 месяца назад

    Is lunacapevir twice yearly for only prevention or for both treatment.

  • @billm1826
    @billm1826 9 месяцев назад +4

    CEO - O’Day has done nothing for this stock price.
    He needs to resign.
    This stock has done nothing since 2014-2015.
    GILD needs new leadership and vision for growth!

  • @jamesgregory9577
    @jamesgregory9577 8 месяцев назад +1

    at least the interviewer is on drugs too so he can talk about it with some real life experience

  • @metalcraze
    @metalcraze 5 месяцев назад

    Yea right.... ask the people working at the Oceanside Gilead Kite in California Facility how they're really doing. Foster City has they pulling the plug the Oceanside Facility and just a matter of time everyone is back in the unemployment line. It was all a poop show to begin with.